₹1,473.2
▲ +0.5%
31 Jul
Cipla Ltd is a leading Indian pharmaceutical company engaged in the manufacture and distribution of generic medicines, branded pharmaceuticals, and active pharmaceutical ingredients across domestic and international markets. The company operates through multiple business segments including Indian pharmaceuticals, international pharmaceuticals, and APIs, serving customers in therapeutic areas such as respiratory, cardiovascular, gastrointestinal, and anti-infective treatments. Cipla maintains a significant presence in India's domestic pharmaceutical market and has established operations across numerous countries globally.
● hover near green dot for dividend
| Period | Revenue (cr) | Expenses (cr) | Op. Profit (cr) | Other Inc. (cr) | Interest (cr) | Dep. (cr) | PBT (cr) | Net Profit (cr) | EPS |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2026 | 7,119 | 5,716 | 1,192 | 211 | 17.03 | 304 | 1,082 | 786 | ₹9.77 |
| Mar 2026 | 6,541 | 5,438 | 955 | 148 | 13.13 | 383 | 707 | 543 | ₹6.87 |
| Dec 2025 | 7,074 | 5,613 | 1,255 | -69.57 | 14.03 | 278 | 893 | 674 | ₹8.37 |
| Sep 2025 | 7,589 | 5,426 | 1,895 | 269 | 13.18 | 297 | 1,854 | 1,353 | ₹16.73 |
| Jun 2025 | 6,957 | 4,921 | 1,778 | 259 | 14.05 | 253 | 1,770 | 1,292 | ₹16.07 |
| Mar 2025 | 6,730 | 4,903 | 1,538 | 289 | 14.02 | 309 | 1,504 | 1,214 | ₹15.13 |
| Dec 2024 | 7,073 | 4,862 | 1,989 | 222 | 15.00 | 280 | 1,916 | 1,575 | ₹19.45 |
| Sep 2024 | 7,051 | 4,975 | 1,885 | 191 | 15.00 | 272 | 1,789 | 1,305 | ₹16.13 |
| Jun 2024 | 6,694 | 4,818 | 1,716 | 160 | 18.00 | 247 | 1,611 | 1,175 | ₹14.58 |
| Mar 2024 | 6,163 | 4,598 | 1,316 | 249 | 18.00 | 288 | 1,259 | 932 | ₹11.63 |
| Dec 2023 | 6,604 | 4,867 | 1,747 | -10.00 | 30.00 | 233 | 1,474 | 1,068 | ₹13.08 |
| Sep 2023 | 6,678 | 4,768 | 1,734 | 176 | 26.00 | 290 | 1,594 | 1,155 | ₹14.01 |
| Jun 2023 | 6,329 | 4,699 | 1,494 | 136 | 16.00 | 239 | 1,375 | 998 | ₹12.33 |
| Mar 2023 | 5,739 | 4,614 | 1,173 | -48.00 | 34.00 | 346 | 745 | 522 | ₹6.51 |
| Dec 2022 | 6,604 | — | 1,748 | — | — | — | — | 1,068 | ₹13.08 |
| Sep 2022 | 6,678 | — | 1,734 | — | — | — | — | 1,155 | ₹14.01 |
| Jun 2022 | 6,329 | — | 1,494 | — | — | — | — | 998 | ₹12.33 |
| Period | Total Assets (cr) | Total Equity (cr) | Total Debt (cr) | D/E |
|---|---|---|---|---|
| Mar 2026 | 42,496 | 34,432 | 258 | 0.01 |
| Mar 2025 | 37,387 | 31,193 | 92.10 | 0.00 |
| Mar 2024 | 32,533 | 26,706 | — | — |
| Mar 2023 | 29,300 | 23,407 | — | — |
| Period | Operating (cr) | Investing (cr) | Financing (cr) | Net Cash (cr) | Free Cash Flow (cr) |
|---|---|---|---|---|---|
| Mar 2026 | 3,940 | -2,326 | -1,234 | 380 | 928 |
| Mar 2025 | 5,005 | -3,691 | -1,293 | 21.05 | 3,490 |
